Mangiferin Ameliorates 6-Hydroxydopamine- Induced

Total Page:16

File Type:pdf, Size:1020Kb

Mangiferin Ameliorates 6-Hydroxydopamine- Induced Pharmacological Reports Copyright © 2012 2012, 64, 848856 by Institute of Pharmacology ISSN 1734-1140 Polish Academy of Sciences Mangiferinameliorates6-hydroxydopamine- inducedcytotoxicityandoxidativestressin ketaminemodelofschizophrenia VietlaS.Rao1,AnaC.Carvalho1,MariaTeresaS.Trevisan2, GeanneM.Andrade1,HelioV.NobreJúnior1,ManoelO.Moraes1, HemersonI.MagalhãesH.Iury1,TalitaC.Morais1,FlaviaA.Santos1 1 DepartmentofPhysiologyandPharmacology,FederalUniversityofCeará,CelNunesdeMelo-1127, CaixaPostal-3157,60430-270Fortaleza,CE,Brazil 2 DepartmentofOrganicandInorganicChemistry,FederalUniversityofCeara,Fortaleza,CE,Brazil Correspondence: VietlaS.Rao,e-mail:[email protected];[email protected] Abstract: Background: Accumulating evidence indicates that mangiferin (MGF), a natural xanthone, by virtue of its antioxidant and anti- inflammatory properties is neuroprotective. Here we sought to verify the cytoprotective role of MGF on cultured rat primary mesen- cephalic cells exposed to 6-hydroxydopamine (6-OHDA) in vitro, and the MGFs anti-inflammatory potential in mouse model of ketamine-inducedschizophrenia invivo. Methods: 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT)-assay was performed to measure cell viability in mesen- cephalic cell cultures exposed to neurotoxin (6-OHDA, 40 µM). Schizophrenia was induced in mice by ketamine (50 mg/kg, ip, twice a day, for 7 days). The treatment effects of MGF (50 mg/kg, po, for 7 days) were verified on locomotor behavioral changes in open-field test, and on the oxidant stress-related increase in lipid-peroxidation (malondialdehyde) and interleukin-6 (IL-6) levels in brain tissues. Results: MGF (10–100 µM) produced no per se effect on cell viability as measured by MTT assay, but significantly prevented the 6-OHDA-induced cell death in a concentration-dependent manner. Acridine orange/ethidium bromide (AO/EtBr) staining con- firmed the absence of 6-OHDA-induced morphological changes characteristic of apoptosis/necrosis. In open-field test, ketamine- induced impaired locomotor activity and behavioral changes such as grooming and stereotyped but not rearing were effectively ame- liorated by MGF pretreatment. Also, ketamine-associated increase in brain tissue levels of IL-6 and MDAwere significantly lowered inMGF-pretreatedmice. Conclusion: Mangiferin has a neurocytoprotective role related, at least in part, to an antioxidant and anti-inflammatory mechanism, whichcouldbeexploredformoreeffectivetherapiesofschizophreniaandotherneurodegenerativediseases. Keywords: mangiferin,cytoprotection,mesencephaliccellculture,6-OHDA,ketamine,oxidativestress Abbreviations: AO/EtBr – acridine orange/ethidium bromide, Introduction DMSO – dimethyl sulfoxide, FBS – fetal bovine serum, IL-6 – interleukin-6, MDA – malondialdehyde, MEM – minimum essen- tial medium, MGF – mangiferin, MTT – 3-(4,5-dimethylthiazol- The brain is susceptible to oxidative damage due to its 2-yl)-2,5-diphenyltetrazolium bromide, MW – molecular weight, high lipid content and oxygen consumption. Neurode- 6-OHDA – 6-hydroxydopamine, PBS – phosphate buffer solu- tion, PI – propidium iodide, SOD – superoxide dismutase, generative diseases like Alzheimer, Parkinson, bipolar TBARS – thiobarbituric acid reactive substances disorder, epilepsy and schizophrenia are problems of 848 Pharmacological Reports, 2012, 64, 848856 Mangiferinpreventscytotoxicityandoxidativestress Vietla S. Rao et al. vast clinical importance. Free iron can react with eral traditional medicinal plants [16] has been shown H2O2 via the Fenton reaction, a primary cause of lipid to produce multiple pharmacological effects that in- peroxidation, and may be of particular importance for clude antioxidant and anti-inflammatory [2, 4, 32], these disorders [1]. Schizophrenia is a severe brain immunomodulatory [20, 26], and neuroprotective [9, disorder characterized by hallucinations, disordered 33] activities. There have been reports that MGF de- thinking and deficiencies in cognition and it has been creases glutamate-induced neurotoxicity and memory suggested that environmental factors combined with loss induced by scopolamine [23, 27, 39]. We previ- a genetic predisposition result in the manifestation of ously demonstrated that MGF affords gastroprotec- this disease [25]. Despite its high incidence in general tion against absolute ethanol or indomethacin-induced population, lack of adequate understanding on the pa- gastric ulceration through an antioxidant mechanism thophysiology of schizophrenia makes the treatment [10]. Impaired antioxidant defenses are suggested to options difficult. Extensive evidence indicates that the participate in the pathophysiology of schizophrenia glutamatergic N-methyl-D-aspartate (NMDA) neuro- and other neurodegenerative conditions. Altered su- transmission is highly disrupted resulting in severe peroxide dismutase (SOD) and increased lipid peroxi- cognitive dysfunction and this pathway seems to be dation, measured by the thiobarbituric acid reactive highly deregulated in experimental models of schizo- substances (TBARS/MDA), are increased in schizo- phrenia that simulate the symptoms of schizophrenia phrenic patients [17]. Besides, MGF has the iron com- [6, 11, 28, 35, 43]. Some other studies indicated brain plexing ability and can protect against Fe2+-citrate in- histaminergic neuronal system involvement in the duced lipid peroxidation [3]. The neurotoxin 6-OHDA pathogenesis of schizophrenia based on the protection is well-known to cause neuronal death by a free offered by histamine 3-receptor antagonists/inverse radical-mediated mechanism as well as by inhibiting agonists in the established animal models of schizo- the mitochondrial complex I and IV [18]. As MGF phrenia[29,30]. has a wide spectrum of pharmacological activity in- Drugs used to treat schizophrenia include the older cluding antioxidant and anti-inflammatory activity generation medications such as chlorpromazine, [26, 32] and accumulating evidence suggests that haloperidol, perphenazine and fluphenazine, which MGF is neuroprotective, the current study is aimed are known to cause extrapyramidal side effects. On to examine the cytoprotective role of MGF against the other side, the newer generation drugs including 6-OHDA-induced neurotoxicity in cultured rat pri- the atypical antipsychotics like clozapine, risperidone, mary mesencephalic cells and its beneficial effects in olanzapine, quetiapine, and ziprasidone have little or the mouse model of ketamine-induced schizhophrenia. no side effects. Due to the low acceptability of these synthetics, the search has been shifted to the natural products having antioxidant and anti-inflammatory properties, which can afford better health promoting effects,comparedtosynthetics. MaterialsandMethods Mangiferin (MGF), a naturally occurring gluco- sylxanthone (Fig. 1) commonly encountered in sev- Animals Male Swiss mice (7–8 weeks old, 20–25 g) and adult male/female Wistar rats (4–5 months old) obtained from the Central Animal House of Federal University of Ceará, were used. They were housed in environ- mentally controlled conditions (23 ± 2°C, 12-h light- dark cycle), with free access to standard diet (Purina Chow) and water ad libitum. Rats were mated to ob- tain rats on pregnancy and to collect embryonic mes- encephalic cells, for in vitro studies. Mice were used for in vivo experiments aimed to study the effects of Fig. 1. Chemical structure of mangiferin (1,3,6,7-tetrahydroxy- drugs in ketamine model of schizophrenia. The xanthoneC2-D-glucoside) experimental protocols were approved by the Animal Pharmacological Reports, 2012, 64, 848856 849 Care and Use Committee of the Federal University of ProtectiveeffectofMGFagainstcelldeath Ceara in accordance with the ethical guidelines of the inducedby6-OHDA International Association for the Study of Pain Mesencephalic cell culture plates having a cell den- (IASP). 4 sity of 5 × 10 cells per well were pre-incubated with MGF in concentrations of 10, 30, and 100 µM for 15 min, prior to addition of 6-OHDA (40 µM). Each Chemicals concentration of MGF was tested in six replicates and repeated three times in separate experiments. Cell Mangiferin (MGF) was extracted and isolated from viability after exposure to 6-OHDA or MGF (10, 30, the bark of Mangifera indica L. (Anacardiaceae) as and 100 µM) alone, or in combination was deter- per procedures reported earlier [10]. The isolated mined in culture plates by MTT as described by Mos- MGF was approximately of 95% purity [4] having the mann [36]. This method measures mitochondrial molecular weight (MW) 422.5 and melting point activity based on the reductive cleavage of yellow (m.p.) 271°C. Minimum essential medium (MEM), tetrazolium salt to a purple formazan compound by trypsin, MTT [3-(4,5-dimethylthiazol-2-yl)-2,5-di- the dehydrogenase activity of intact mitochondria. phenyltetrazolium bromide], cytochalasin-B, propid- Briefly, cells were washed once with PBS before the ium iodide (PI), ethidium bromide (EtBr) and fetal addition of 0.1 ml of serum free medium containing bovine serum (FBS) were purchased from Sigma MTT (1 mg/ml) to each well. After incubation for 3 h, Chemical Co. (St. Louis, MO, USA). Acridine orange the supernatant was removed and the formazan prod- uct obtained was dissolved in 1 ml dimethyl sulfoxide (AO) was purchased from BDH Chemicals Ltd., (DMSO) with stirring for 15 min on a microtiter plate Poole, England and ketamine from Sigma-Aldrich shaker and the absorbance was read at 550 nm. The (MO, USA). MGF was dissolved in 0.02% DMSO
Recommended publications
  • Alzheimer's Disease, a Decade of Treatment: What Have We Learned?
    A Critical Look at Medication Dementia: Alzheimer’s Disease Management Issues in Alzheimer’s Disease R.Ron Finley, B.S. Pharm., R.Ph,CGP Lecturer (Emeritus) and Assistant Clinical Professor, UCSF School of Pharmacy Clinical Pharmacist, UCSF Memory and Aging Center- Alzheimer’s Research Center Educational Objectives Disclosures 1. Define the role for cholinesterase inhibitors in the management of Alzheimer’s disease, Lewy Body dementia, Frontal Temporal Lobe dementia. Pfizer Speakers Bureau 2. Name three common side effects of atypical antipsychotic Forest Speakers Bureau drugs. Novartis Speakers Bureau 3. Construct a pharmacological treatment plan for a 77-year-old Rx Consultant Associate Editor patient diagnosed with Alzheimer’s disease and hallucinations. WindChime Consultant 4. Describe the role for antipsychotic, antidepressant, mood HGA HealthCare Consultant stabilizers and benzodiazepines in the management of psychiatric behavior problems related to Alzheimer’s disease. Elder Care Specialist Consultant 5. Cite three potential drug or disease interactions with cholinesterase inhibitors. The Many Faces of Dementia Risk Factors Linked to AD Alzheimer’s Disease Over 65 years of age and increases Vascular: Multi-infarct with age FrontalTemporal Lobe dementia ( FTD) and female Pick’s disease Head injury Lewy Body Dementia Progressive Supranuclear Palsy Factors associated with DM, HTN, CVD Corticobasal Degeneration Genetic: family history, specific Primary Progressive Aphasia chromosome mutations Huntington’s disease
    [Show full text]
  • INVESTIGATION of NATURAL PRODUCT SCAFFOLDS for the DEVELOPMENT of OPIOID RECEPTOR LIGANDS by Katherine M
    INVESTIGATION OF NATURAL PRODUCT SCAFFOLDS FOR THE DEVELOPMENT OF OPIOID RECEPTOR LIGANDS By Katherine M. Prevatt-Smith Submitted to the graduate degree program in Medicinal Chemistry and the Graduate Faculty of the University of Kansas in partial fulfillment of the requirements for the degree of Doctor of Philosophy. _________________________________ Chairperson: Dr. Thomas E. Prisinzano _________________________________ Dr. Brian S. J. Blagg _________________________________ Dr. Michael F. Rafferty _________________________________ Dr. Paul R. Hanson _________________________________ Dr. Susan M. Lunte Date Defended: July 18, 2012 The Dissertation Committee for Katherine M. Prevatt-Smith certifies that this is the approved version of the following dissertation: INVESTIGATION OF NATURAL PRODUCT SCAFFOLDS FOR THE DEVELOPMENT OF OPIOID RECEPTOR LIGANDS _________________________________ Chairperson: Dr. Thomas E. Prisinzano Date approved: July 18, 2012 ii ABSTRACT Kappa opioid (KOP) receptors have been suggested as an alternative target to the mu opioid (MOP) receptor for the treatment of pain because KOP activation is associated with fewer negative side-effects (respiratory depression, constipation, tolerance, and dependence). The KOP receptor has also been implicated in several abuse-related effects in the central nervous system (CNS). KOP ligands have been investigated as pharmacotherapies for drug abuse; KOP agonists have been shown to modulate dopamine concentrations in the CNS as well as attenuate the self-administration of cocaine in a variety of species, and KOP antagonists have potential in the treatment of relapse. One drawback of current opioid ligand investigation is that many compounds are based on the morphine scaffold and thus have similar properties, both positive and negative, to the parent molecule. Thus there is increasing need to discover new chemical scaffolds with opioid receptor activity.
    [Show full text]
  • Impact of Using Organic Yeast in the Fermentation Process of Wine
    processes Article Impact of Using Organic Yeast in the Fermentation Process of Wine Balázs Nagy 1, Zsuzsanna Varga 2,Réka Matolcsi 1, Nikolett Kellner 1 , Áron Szövényi 1 and Diána Nyitrainé Sárdy 1,* 1 Faculty of Horticultural Science Department of Oenology, Szent István University, 1118 Budapest, Hungary; [email protected] (B.N.); [email protected] (R.M.); [email protected] (N.K.); [email protected] (Á.S.) 2 Faculty of Horticultural Science Department of Viticulture, Szent István University, 1118 Budapest, Hungary; [email protected] * Correspondence: [email protected] Abstract: The aim of this study was to find out what kind of “Bianca” wine could be produced when using organic yeast, what are the dynamics of the resulting alcoholic fermentation, and whether this method is suitable for industrial production as well. Due to the stricter rules and regulations, as well as the limited amount and selection of the permitted chemicals, resistant, also known as interspecific or innovative grape varieties, can be the ideal basic materials of alternative cultivation technologies. Well-designed analytical and organoleptic results have to provide the scientific background of resistant varieties, as these cultivars and their environmentally friendly cultivation techniques could be the raw materials of the future. The role of the yeast in wine production is crucial. We fermented wines from the “Bianca” juice samples three times where model chemical solutions were applied. In our research, we aimed to find out how organic yeast influenced the biogenic amine formation of three important compounds: histamine, tyramine, and serotonin. The main results of this study showed that all the problematic values (e.g., histamine) were under the critical limit (1 g/L), although the organic samples resulted in a significantly higher level than the control wines.
    [Show full text]
  • Synthetic Drugs
    Comprehensive and Confident Identification of Narcotics, Steroids and Pharmaceuticals in Urine David E. Alonso1, Petra Gerhards2, Charles Lyle1 and Joe Binkley1 | 1LECO Corporation, St. Joseph, MI; 2LECO European LSCA Centre, Moenchengladbach, Germany Introduction Experimental Sample A (Traditional Drugs) Sample B (Synthetic Drugs) Monitoring of patients in hospitals and clinics has traditionally relied on Samples Representative Compounds Representative Compounds targeted methods of analysis. These screening methods are not Peak # Name Formula R.T. (s) Area Similarity Mass Delta (mDa) MA (ppm) 1 Creatinine ME C5H9N3O 210 1326229 800 -0.05 -0.43 • Obtained from a collaborating European hospital 3.5e6 3.0e6 Peak # Name Formula R.T. (s) Area Similarity 2 o-Ethynylaniline C8H7N 219 167436 893 0.07 0.63 1 Indole C8H7N 213 2744171 917 comprehensive and result in an incomplete picture of a patient’s 3 2-Methoxy-4-vinylphenol C H O 223 65764 805 0.11 0.73 52 patient monitoring samples 9 10 2 2 Creatinine ME C5H9N3O 216 613318 651 • 2.5e6 4 Nicotine C10H14N2 234 3249121 898 -0.21 -1.29 3 Pyridine, 2-(1-methyl-2-pyrrolidinyl)- C10H14N2 230 24869771 899 activities. Gas chromatography high resolution time-of-flight mass 3.0e6 5 Hordenin C10H15NO 274 949734 775 -0.14 -0.84 4 Parabanic acid, 1-methyl- C4H4N2O3 233 434278 764 Sample preparation 5 Cotinine C10H12N2O 336 27810908 918 • 6 Methylecgonine C10H17NO3 276 104640 835 -0.22 -1.1 spectrometry (GC-HRT) provides a fast and convenient method for 2.0e6 5 6 Caffeine C8H10N4O2 371 3753598 797 2.5e6 7 4-(3-Pyridyl-tetrahydrofuran-2-one C9H9NO2 313 93817 849 -0.11 -0.68 3,4 7 1-methyl-7H-xanthine C6H6N4O2 437 4868196 850 analysis of urine samples.
    [Show full text]
  • Crofelemer Oral Delayed Release Tablet
    Contains Nonbinding Recommendations Draft – Not for Implementation Draft Guidance on Crofelemer This draft guidance, when finalized, will represent the current thinking of the Food and Drug Administration (FDA, or the Agency) on this topic. It does not establish any rights for any person and is not binding on FDA or the public. You can use an alternative approach if it satisfies the requirements of the applicable statutes and regulations. To discuss an alternative approach, contact the Office of Generic Drugs. Active Ingredient: Crofelemer Dosage Form; Route: Tablet, delayed release; oral Strength: 125 mg Recommendations for the Assessment of Identity and Quality of Botanical Raw Material (BRM): Crofelemer is a botanical drug derived from BRM, the crude red latex of Croton lechleri Müll. Arg. [Fam. Euphorbiacae], which is also called dragon’s blood (sangre de drago). Generic drug applicants should use the same plant species and perform BRM assessment: 1. Crofelemer BRM should be collected from the crude red latex of Croton lechleri. The plant species should be correctly identified and authenticated based on techniques such as macroscopic/microscopic and/or analysis of genetic material. 2. Crude red latex as BRM should be collected from the mature tree with defined eco- geographic regions (EGRs). Implementing and enforcing established good agricultural and collection practice (GACP) procedures will minimize variations in BRM and ensure batch- to-batch consistency of crofelemer. 3. BRMs should be analyzed for their crofelemer content, total phenolics and taspine content, as well as heavy metals and pesticides. Recommendations for Demonstrating API Sameness: API sameness can be established by showing equivalence between Test API and API from the reference listed drug (RLD) product with the three criteria described in detail below.
    [Show full text]
  • Upregulation of Peroxisome Proliferator-Activated Receptor-Α And
    Upregulation of peroxisome proliferator-activated receptor-α and the lipid metabolism pathway promotes carcinogenesis of ampullary cancer Chih-Yang Wang, Ying-Jui Chao, Yi-Ling Chen, Tzu-Wen Wang, Nam Nhut Phan, Hui-Ping Hsu, Yan-Shen Shan, Ming-Derg Lai 1 Supplementary Table 1. Demographics and clinical outcomes of five patients with ampullary cancer Time of Tumor Time to Age Differentia survival/ Sex Staging size Morphology Recurrence recurrence Condition (years) tion expired (cm) (months) (months) T2N0, 51 F 211 Polypoid Unknown No -- Survived 193 stage Ib T2N0, 2.41.5 58 F Mixed Good Yes 14 Expired 17 stage Ib 0.6 T3N0, 4.53.5 68 M Polypoid Good No -- Survived 162 stage IIA 1.2 T3N0, 66 M 110.8 Ulcerative Good Yes 64 Expired 227 stage IIA T3N0, 60 M 21.81 Mixed Moderate Yes 5.6 Expired 16.7 stage IIA 2 Supplementary Table 2. Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analysis of an ampullary cancer microarray using the Database for Annotation, Visualization and Integrated Discovery (DAVID). This table contains only pathways with p values that ranged 0.0001~0.05. KEGG Pathway p value Genes Pentose and 1.50E-04 UGT1A6, CRYL1, UGT1A8, AKR1B1, UGT2B11, UGT2A3, glucuronate UGT2B10, UGT2B7, XYLB interconversions Drug metabolism 1.63E-04 CYP3A4, XDH, UGT1A6, CYP3A5, CES2, CYP3A7, UGT1A8, NAT2, UGT2B11, DPYD, UGT2A3, UGT2B10, UGT2B7 Maturity-onset 2.43E-04 HNF1A, HNF4A, SLC2A2, PKLR, NEUROD1, HNF4G, diabetes of the PDX1, NR5A2, NKX2-2 young Starch and sucrose 6.03E-04 GBA3, UGT1A6, G6PC, UGT1A8, ENPP3, MGAM, SI, metabolism
    [Show full text]
  • Management of Chronic Problems
    MANAGEMENT OF CHRONIC PROBLEMS INTERACTIONS BETWEEN ALCOHOL AND DRUGS A. Leary,* T. MacDonald† SUMMARY concerned. Alcohol may alter the effects of the drug; drug In western society alcohol consumption is common as is may change the effects of alcohol; or both may occur. the use of therapeutic drugs. It is not surprising therefore The interaction between alcohol and drug may be that concomitant use of these should occur frequently. The pharmacokinetic, with altered absorption, metabolism or consequences of this combination vary with the dose of elimination of the drug, alcohol or both.2 Alcohol may drug, the amount of alcohol taken, the mode of affect drug pharmacokinetics by altering gastric emptying administration and the pharmacological effects of the drug or liver metabolism. Drugs may affect alcohol kinetics by concerned. Interactions may be pharmacokinetic or altering gastric emptying or inhibiting gastric alcohol pharmacodynamic, and while coincidental use of alcohol dehydrogenase (ADH).3 This may lead to altered tissue may affect the metabolism or action of a drug, a drug may concentrations of one or both agents, with resultant toxicity. equally affect the metabolism or action of alcohol. Alcohol- The results of concomitant use may also be principally drug interactions may differ with acute and chronic alcohol pharmacodynamic, with combined alcohol and drug effects ingestion, particularly where toxicity is due to a metabolite occurring at the receptor level without important changes rather than the parent drug. There is both inter- and intra- in plasma concentration of either. Some interactions have individual variation in the response to concomitant drug both kinetic and dynamic components and, where this is and alcohol use.
    [Show full text]
  • THE POSSIBLE ROLE of LEUKOCYTE-GENERATED Reactrve INTERMEDIATES in the DRUG-INDUCED Agrancnocytosis
    THE POSSIBLE ROLE OF LEUKOCYTE-GENERATED REACTrVE INTERMEDIATES IN THE DRUG-INDUCED AGRANCnOCYTOSIS Zhao Chao Liu A thesis submitted in conformity with the requirements for the degree of Doctor of Philosophy Faculty of Pharmacy University of Toronto O Copyright by Zhao Chao Liu 1997 National Library Bibliothèque nationale (*m of Canada du Canada Acquisitions and Acquisitions et Bibliographic Services services bibliographiques 395 Wellington Street 395, rue Wellington Ottawa ON K1A ON4 Ottawa ON KIA ON4 Canada Canada The author has granted a non- L'auteur a accordé une licence non exclusive licence allowing the exclusive permettant a la National Library of Canada to Bibliothèque nationale du Canada de reproduce, loan, distribute or seil reproduire, prêter, distribuer ou copies of this thesis in microform, vendre des copies de cette thèse sous paper or electronic formats. la fome de microfiche/£ïlm, de reproduction sur papier ou sur format électronique. The author retains ownership of the L'auteur conserve la propriété du copyright in this thesis. Neither the droit d'auteur qui protège cette thèse. thesis nor substantial extracts fkom it Ni la thèse ni des extraits substantiels may be printed or otherwise de celle-ci ne doivent être imprimés reproduced without the author's ou autrement reproduits sans son permission. autorisation. ABSTRACT Ticlopidine and clczapine are associated with relatively high incidences of agranulocytosis. 5-aminosalicylic acid (5-ASA) is an agent widely used in the treatment of inflammatory bowel disease. It has been demonstrated that many drugs associated with drug-induced agranulocytosis or dmg-induced lupus are oxidized by activated neutrophils to reactive intermediates, by the combination of myeloperoxidase (MPO), hydrogen peroxide and chloride ion, or simply by hypochlorous acid (HOCI).
    [Show full text]
  • Green Tea Extract Ameliorate Liver Toxicity and Immune System Dysfunction Induced by Cyproterone Acetate in Female Rats
    Journal of American Science 2010;6(5) Green Tea Extract Ameliorate Liver Toxicity and Immune System Dysfunction Induced by Cyproterone Acetate in Female Rats Heba Barakat Department of Biochemistry and Nutrition,Women`s College, Ain Shams University [email protected] Abstract: Green tea, consumed worldwide since ancient times, is considered beneficial to human health. The present study aimed to evaluate the effect of green tea extract (GTE) on liver damage and immune system function in female rats treated with cyproterone acetate (CPA). Forty healthy female adult albino rats were randomly assigned to four groups. Group (1) was fed on a standard diet as a control. Group (2) was fed on a standard diet and received an intraperitoneally injection of 25mg/Kg/day. Group (3) was fed on a standard diet supplemented with 1 g GTE% and received a daily injection. Group (4) was fed on the supplemented diet for 7 days prior to receiving the daily injection. The experimental duration lasted for 3 weeks initiated from the first injection. The results showed CPA alone led to diminish liver function, hepatic antioxidant enzyme activities and elevated hepatic oxidative stress and serum IgG and IgM levels comparing with the control group of rats. However, the ingestion of GTE either along with or prior to the CPA treatment could significantly improve the function of liver, hepatic oxidative stress and hepatic antioxidant status and elevate the IgG and IgM levels. These data suggested that, GTE possesses a protective effect on the liver against the induced CPA toxicity by increasing auto immunity and countering the hepatic oxidative stress.
    [Show full text]
  • Antidepressant-Like Behavioral and Neurochemical Effects of the Citrus
    Available online at www.sciencedirect.com Life Sciences 82 (2008) 741–751 www.elsevier.com/locate/lifescie Antidepressant-like behavioral and neurochemical effects of the citrus-associated chemical apigenin ⁎ Li-Tao Yi, Jian-Mei Li, Yu-Cheng Li, Ying Pan, Qun Xu, Ling-Dong Kong State Key Laboratory of Pharmaceutical Biotechnology, School of Life Sciences, Nanjing University, Nanjing 210093, PR China Received 14 July 2007; accepted 16 January 2008 Abstract Apigenin is one type of bioflavonoid widely found in citrus fruits, which possesses a variety of pharmacological actions on the central nervous system. A previous study showed that acute intraperitoneal administration of apigenin had antidepressant-like effects in the forced swimming test (FST) in ddY mice. To better understand its pharmacological activity, we investigated the behavioral effects of chronic oral apigenin treatment in the FST in male ICR mice and male Wistar rats exposed to chronic mild stress (CMS). The effects of apigenin on central monoaminergic neurotransmitter systems, the hypothalamic–pituitary–adrenal (HPA) axis and platelet adenylyl cyclase activity were simultaneously examined in the CMS rats. Apigenin reduced immobility time in the mouse FST and reversed CMS-induced decrease in sucrose intake of rats. Apigenin also attenuated CMS-induced alterations in serotonin (5-HT), its metabolite 5-hydroxyindoleacetic acid (5-HIAA), dopamine (DA) levels and 5-HIAA/ 5-HT ratio in distinct rat brain regions. Moreover, apigenin reversed CMS-induced elevation in serum corticosterone concentrations and reduction in platelet adenylyl cyclase activity in rats. These results suggest that the antidepressant-like actions of oral apigenin treatment could be related to a combination of multiple biochemical effects, and might help to elucidate its mechanisms of action that are involved in normalization of stress- induced changes in brain monoamine levels, the HPA axis, and the platelet adenylyl cyclase activity.
    [Show full text]
  • And Radiation Therapy Sensitizing Strategies in Tumours with Focus on Effects of Phenothiazines on Dna Damage Response Signalling
    From DEPARTMENT OF ONCOLOGY-PATHOLOGY Karolinska Institutet, Stockholm, Sweden ANALYSIS AND CHARACTERIZATION OF CHEMO- AND RADIATION THERAPY SENSITIZING STRATEGIES IN TUMOURS WITH FOCUS ON EFFECTS OF PHENOTHIAZINES ON DNA DAMAGE RESPONSE SIGNALLING Katarzyna Zielinska-Chomej Stockholm 2015 All previously published papers were reproduced with permission from the publisher. Published by Karolinska Institutet. Printed by E-Print AB 2015 © Katarzyna Zielinska-Chomej, 2015 ISBN 978-91-7549-898-0 Analysis and characterization of chemo- and radiation therapy sensitizing strategies in tumours with focus on effects of phenothiazines on DNA damage response signalling THESIS FOR DOCTORAL DEGREE (Ph.D.) Dept of Oncology-Pathology, Cancer Center Karolinska (CCK) Lecture Hall, R8:00, Karolinska University Hospital, Stockholm Friday, the 16th of October, 2015, at 09:00 By Katarzyna Zielinska-Chomej Principal Supervisor: Opponent: Kristina Viktorsson, PhD Associate Prof Karin Roberg, MD, PhD Karolinska Institutet Linköping University Department of Oncology-Pathology Department of Clinical and Experimental Medicine Division of Otorhinolaryngology Co-supervisor(s): Petra Hååg, PhD Examination Board: Karolinska Institutet Associate Prof Marika Nestor, MD, PhD Department of Oncology-Pathology Uppsala University Department of Surgical Sciences, Otolaryngology and Head & Neck Surgery and Department of Professor Rolf Lewensohn, MD, PhD Immunology, Genetics and Pathology Karolinska Institutet Division of Biomedical Radiation Sciences Department of Oncology-Pathology
    [Show full text]
  • What Is Old Is New…
    8/20/2015 WHAT’S COMING DOWN THE PIPELINE? NEWER AND FUTURE ANESTHETIC AND ANALGESIC DRUGS FOR THE SMALL ANIMAL PRACTITIONER. ANESTHESIA AND ANALGESIA Looking for the next “great” tool in the box New drugs and new uses for old drugs Improve patient care and maximize outcomes WHAT IS OLD IS NEW… Methadone Fentanyl (topical) Buprenorphine (transmucosal) Etomidate Meloxicam (transmucosal spray) Robenaxocib 1 8/20/2015 WHAT IS NEW IS NEW… Propoflo 28® (propofol with an increased shelf life) Remifentanil Alenza Simbadol™ ‐ Long acting buprenorphine Alfaxan®‐ CD (alfaxalone) METHADONE Pure µ agonist opioid (synthetic) NMDA antagonist May be best opioid for chronic pain Better analgesic than buprenorphine for 8 hours post operatively Less vomiting and panting than hydromorphone and morphine in dogs Does not seem to elicit aggressive behavior in cats Can be expensive, can not be administered orally (unlike in humans) Dosages Dogs 0.25 to 0.5 mg/kg, IM or IV Cats 0.1 mg/kg, IM or IV FENTANYL (TOPICAL) Recuvyra™ Transdermal solution Topical application in dogs only 50 mg/ml fentanyl (Class II controlled substance) Risk Minimization Action Plan (RiskMAP) Educational materials to veterinarian, staff and owners 2 8/20/2015 FENTANYL (TOPICAL) RiskMAP Owner must read and sign client information sheet before application Only available through a restricted distribution program Certified distributors Veterinarian must take online training prior to being able to purchase High potential for human abuse and safety risks FENTANYL (TOPICAL) Use Administered by two trained veterinarians or staff Protective clothing –gloves, lab coats, and glasses or face shield Applied directly to the skin in the dorsal scapular area.
    [Show full text]